Last reviewed · How we verify
NCT07543458
Therapeutics for Moderate and Severe Dengue
Not yet recruiting
Phase 3
What this trial tests
Phase 3 trial testing Placebo in Dengue in 8,800 participants. Not yet recruiting.
Timeline
1 October 2026
31 July 2031
Quick facts
| Lead sponsor | Oxford University Clinical Research Unit, Vietnam |
|---|---|
| Phase | Phase 3 |
| Status | Not yet recruiting |
| Enrollment | 8,800 |
| Start date | 1 October 2026 |
| Estimated completion | 31 July 2031 |
Drugs / interventions tested
- Placebo
- Dexamethasone (dexamethasone) — full drug profile →
- N-Acetylcysteine — full drug profile →
- Standard of care
- Baricitinib (baricitinib) — full drug profile →
Conditions studied
- Dengue — all drugs for Dengue →
- Severe Dengue — all drugs for Severe Dengue →
- Mosquito-Borne Diseases — all drugs for Mosquito-Borne Diseases →
- Vector Borne Diseases — all drugs for Vector Borne Diseases →
Sponsor
Oxford University Clinical Research Unit, Vietnam
Who can join
Eligibility, any sex, with Dengue or Severe Dengue.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07543458
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dexamethasone
Trials testing the same drug.
- NCT07175415 — HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological · Phase 1, PHASE2 · not yet recruiting
- NCT07513129 — A Phase 1 Study Of Venetoclax, Dexamethasone, Bortezomib, And Daratumumab (VDBD) For Adolescent And Young Adult Patients · Phase 1 · not yet recruiting
- NCT07444710 — Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) · Phase 1 · not yet recruiting
- NCT07387926 — Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+ · Phase 1, PHASE2 · not yet recruiting
- NCT07343817 — IV Injection of Metoclopramide With or Without Dexamethasone · EARLY_PHASE1 · not yet recruiting
Other recruiting trials for Dengue
Currently open trials in the same condition.
- NCT07501793 — Demographic Characteristics of TAK-003 Dengue Vaccine Recipients in Vietnam · active not recruiting
- NCT07358910 — Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective · recruiting
- NCT07007585 — Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection · recruiting
- NCT06894901 — Impact of IIT-SIT on Dengue Clusters · NA · recruiting
- NCT07158190 — Evaluation of T-cell Responses After Vaccination With the Attenuated Tetravalent Dengue Vaccine (Takeda). · active not recruiting
Other Oxford University Clinical Research Unit, Vietnam trials
Trials by the same sponsor.
- NCT06551844 — Adaptive Dengue Antiviral Platform Trial · Phase 2 · not yet recruiting
- NCT05909384 — Management of Sepsis in Resource Limited Settings Using a Delphi Method. · completed
- NCT05611710 — Anakinra in Dengue With Hyperinflammation ( AnaDen ) · Phase 2 · active not recruiting
- NCT05083130 — Awake Prone Positioning in Moderate to Severe COVID-19 · NA · completed
- NCT04349826 — The Azithromycin and Cefixime Treatment of Typhoid in South Asia Trial (ACT-South Asia Trial) · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
Data sources for this page
- Trial protocol + status: ClinicalTrials.gov NCT07543458 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oxford University Clinical Research Unit, Vietnam
- Last refreshed: recently
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07543458.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing